Dr. Mark N. Hendrixson, MD
Medical Oncology (Medical Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Tennessee, Hsc, College of Medicine (1990)
- Years since graduation
- 36
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 491
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1990Medical school: University of Tennessee, Hsc, College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
TN license MD021724
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University Health System, Inc Knoxville, TN
- Cookeville Regional Medical Center Cookeville, TN
- Cumberland Medical Center Crossville, TN
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 491
- Services billed
- 213,225
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, ferric carboxymaltose, 1 mg | 64,502 | 47 |
| Injection, pembrolizumab, 1 mg | 17,600 | 11 |
| Injection, denosumab, 1 mg | 4,740 | 25 |
| Injection, dexamethasone sodium phosphate, 1 mg | 1,925 | 27 |
| Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 1,800 | 16 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,677 | 398 |
| Insertion of needle into vein for collection of blood sample | 1,241 | 381 |
| Injection, ondansetron hydrochloride, per 1 mg | 945 | 11 |
| Injection, palonosetron hcl, 25 mcg | 910 | 12 |
| Established patient office or other outpatient visit, 30-39 minutes | 798 | 369 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamoxifen Citrate Other prescribers in Crossville, TN | 102 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Crossville, TN | 90 |
| Anastrozole Other prescribers in Crossville, TN | 88 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Crossville, TN | 82 |
| Prednisone Other prescribers in Crossville, TN | 70 |
| Prochlorperazine Maleate Other prescribers in Crossville, TN | 64 |
| Gabapentin Other prescribers in Crossville, TN | 51 |
| Oxycodone Hcl Other prescribers in Crossville, TN | 42 |
| Dexamethasone Other prescribers in Crossville, TN | 42 |
| Levothyroxine Sodium Other prescribers in Crossville, TN | 40 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 46 companies reported 91 payments worth $2,157 in total to this clinician.
| Daiichi Sankyo Inc. | $152 |
|---|---|
| Novartis Pharmaceuticals Corporation | $138 |
| Pfizer Inc. | $137 |
| AstraZeneca Pharmaceuticals LP | $124 |
| Janssen Biotech, Inc. | $112 |
| Seagen Inc. | $91.99 |
| Genzyme Corporation | $86.53 |
| E.r. Squibb & Sons, L.l.c. | $84.17 |
| Food and Beverage | $2,045 |
|---|---|
| Education | $112 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Seagen Inc. Sep 3, 2025 | Education in-kind | $91.99 |
| Aveo Pharmaceuticals, Inc. Mar 27, 2025 | Education FOTIVDA · Oncology · in-kind | $20.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.